Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Citation

• Ryan, C. J., Smith, M. R., De Bono, J. S., Molina, A., Logothetis, C., De Souza, P. L., . . . Rathkopf, D. E. (2012). Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology, 30(18_suppl), lba4518. doi:10.1200/jco.2012.30.18_suppl.lba4518

Digital Object Identifier (doi)

• 10.1200/jco.2012.30.18_suppl.lba4518

Web Of Science Accession Number

Start Page

• lba4518

End Page

• lba4518

Volume

• 30

Issue

• 18_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2012

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Ryan, C. J., Smith, M. R., De Bono, J. S., Molina, A., Logothetis, C., De Souza, P. L., . . . Rathkopf, D. E. (2012). Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology, 30(18_suppl), lba4518. doi:10.1200/jco.2012.30.18_suppl.lba4518

Digital Object Identifier (doi)

• 10.1200/jco.2012.30.18_suppl.lba4518

Web Of Science Accession Number

Start Page

• lba4518

End Page

• lba4518

Volume

• 30

Issue

• 18_suppl

Place Of Publication